These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35626711)

  • 21. Biomarker Profiles in Heart Failure Patients With Preserved and Reduced Ejection Fraction.
    Tromp J; Khan MA; Klip IT; Meyer S; de Boer RA; Jaarsma T; Hillege H; van Veldhuisen DJ; van der Meer P; Voors AA
    J Am Heart Assoc; 2017 Mar; 6(4):. PubMed ID: 28360225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biomarkers for characterization of heart failure - Distinction of heart failure with preserved and reduced ejection fraction.
    Sinning C; Kempf T; Schwarzl M; Lanfermann S; Ojeda F; Schnabel RB; Zengin E; Wild PS; Lackner KJ; Munzel T; Blankenberg S; Wollert KC; Zeller T; Westermann D
    Int J Cardiol; 2017 Jan; 227():272-277. PubMed ID: 27838133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating microRNAs in heart failure with reduced and preserved left ventricular ejection fraction.
    Wong LL; Armugam A; Sepramaniam S; Karolina DS; Lim KY; Lim JY; Chong JP; Ng JY; Chen YT; Chan MM; Chen Z; Yeo PS; Ng TP; Ling LH; Sim D; Leong KT; Ong HY; Jaufeerally F; Wong R; Chai P; Low AF; Lam CS; Jeyaseelan K; Richards AM
    Eur J Heart Fail; 2015 Apr; 17(4):393-404. PubMed ID: 25619197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mortality associated with heart failure with preserved vs. reduced ejection fraction in a prospective international multi-ethnic cohort study.
    Lam CSP; Gamble GD; Ling LH; Sim D; Leong KTG; Yeo PSD; Ong HY; Jaufeerally F; Ng TP; Cameron VA; Poppe K; Lund M; Devlin G; Troughton R; Richards AM; Doughty RN
    Eur Heart J; 2018 May; 39(20):1770-1780. PubMed ID: 29390051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Similarities and differences of myocardial metabolic characteristics between HFpEF and HFrEF mice based on LC-MS/MS metabolomics].
    Zhang ZY; Feng XY; Wang ZH; Huang YZ; Yang WB; Zhang WJ; Zhou J; Yuan ZY
    Zhonghua Xin Xue Guan Bing Za Zhi; 2023 Jul; 51(7):722-730. PubMed ID: 37460426
    [No Abstract]   [Full Text] [Related]  

  • 26. Insulin resistance in heart failure: differences between patients with reduced and preserved left ventricular ejection fraction.
    Scherbakov N; Bauer M; Sandek A; Szabó T; Töpper A; Jankowska EA; Springer J; von Haehling S; Anker SD; Lainscak M; Engeli S; Düngen HD; Doehner W
    Eur J Heart Fail; 2015 Oct; 17(10):1015-21. PubMed ID: 26198713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction.
    Santhanakrishnan R; Chong JP; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong R; Chai P; Low AF; Richards AM; Lam CS
    Eur J Heart Fail; 2012 Dec; 14(12):1338-47. PubMed ID: 22869458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HFpEF and HFrEF exhibit different phenotypes as assessed by leptin and adiponectin.
    Faxén UL; Hage C; Andreasson A; Donal E; Daubert JC; Linde C; Brismar K; Lund LH
    Int J Cardiol; 2017 Feb; 228():709-716. PubMed ID: 27886615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aerobic Interval Training Elicits Different Hemodynamic Adaptations Between Heart Failure Patients with Preserved and Reduced Ejection Fraction.
    Fu TC; Yang NI; Wang CH; Cherng WJ; Chou SL; Pan TL; Wang JS
    Am J Phys Med Rehabil; 2016 Jan; 95(1):15-27. PubMed ID: 26053189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of sarcopenia on prognosis in patients with heart failure with reduced and preserved ejection fraction.
    Konishi M; Kagiyama N; Kamiya K; Saito H; Saito K; Ogasahara Y; Maekawa E; Misumi T; Kitai T; Iwata K; Jujo K; Wada H; Kasai T; Nagamatsu H; Ozawa T; Izawa K; Yamamoto S; Aizawa N; Makino A; Oka K; Momomura SI; Matsue Y
    Eur J Prev Cardiol; 2021 Aug; 28(9):1022-1029. PubMed ID: 33624112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction.
    Sanders-van Wijk S; van Empel V; Davarzani N; Maeder MT; Handschin R; Pfisterer ME; Brunner-La Rocca HP;
    Eur J Heart Fail; 2015 Oct; 17(10):1006-14. PubMed ID: 26472682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic value of highly sensitive cardiac troponin assays for adverse events in men and women with stable heart failure and a preserved vs. reduced ejection fraction.
    Gohar A; Chong JPC; Liew OW; den Ruijter H; de Kleijn DPV; Sim D; Yeo DPS; Ong HY; Jaufeerally F; Leong GKT; Ling LH; Lam CSP; Richards AM
    Eur J Heart Fail; 2017 Dec; 19(12):1638-1647. PubMed ID: 28849609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thromboembolisms in atrial fibrillation and heart failure patients with a preserved ejection fraction (HFpEF) compared to those with a reduced ejection fraction (HFrEF).
    Sobue Y; Watanabe E; Lip GYH; Koshikawa M; Ichikawa T; Kawai M; Harada M; Inamasu J; Ozaki Y
    Heart Vessels; 2018 Apr; 33(4):403-412. PubMed ID: 29067492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HFpEF and HFrEF Display Different Phenotypes as Assessed by IGF-1 and IGFBP-1.
    Faxén UL; Hage C; Benson L; Zabarovskaja S; Andreasson A; Donal E; Daubert JC; Linde C; Brismar K; Lund LH
    J Card Fail; 2017 Apr; 23(4):293-303. PubMed ID: 27327968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA signatures differentiate preserved from reduced ejection fraction heart failure.
    Watson CJ; Gupta SK; O'Connell E; Thum S; Glezeva N; Fendrich J; Gallagher J; Ledwidge M; Grote-Levi L; McDonald K; Thum T
    Eur J Heart Fail; 2015 Apr; 17(4):405-15. PubMed ID: 25739750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bio-profiling and bio-prognostication of chronic heart failure with mid-range ejection fraction.
    Moliner P; Lupón J; Barallat J; de Antonio M; Domingo M; Núñez J; Zamora E; Galán A; Santesmases J; Pastor C; Bayes-Genis A
    Int J Cardiol; 2018 Apr; 257():188-192. PubMed ID: 29415801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peak atrio-ventricular mechanics predicts exercise tolerance in heart failure patients.
    Sengupta SP; Okwose NC; MacGowan GA; Jakovljevic DG
    Int J Cardiol; 2022 Jul; 359():84-90. PubMed ID: 35367509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study.
    Kontogeorgos S; Thunström E; Johansson MC; Fu M
    Int J Cardiol; 2017 Apr; 232():86-92. PubMed ID: 28100428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myocardial expression of somatotropic axis, adrenergic signalling, and calcium handling genes in heart failure with preserved ejection fraction and heart failure with reduced ejection fraction.
    D'Assante R; Arcopinto M; Rengo G; Salzano A; Walser M; Gambino G; Monti MG; Bencivenga L; Marra AM; Åberg DN; De Vincentiis C; Ballotta A; Bossone E; Isgaard J; Cittadini A
    ESC Heart Fail; 2021 Apr; 8(2):1681-1686. PubMed ID: 33512777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ventricular-Arterial Coupling and Exercise-Induced Pulmonary Hypertension During Low-Level Exercise in Heart Failure With Preserved or Reduced Ejection Fraction.
    Obokata M; Nagata Y; Kado Y; Kurabayashi M; Otsuji Y; Takeuchi M
    J Card Fail; 2017 Mar; 23(3):216-220. PubMed ID: 27737768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.